Eun Ja Kwon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eun Ja Kwon has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Byong Duk Ye
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
2 shared publications - Sang Hyoung Park
Department of Gastroenterology and Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
2 shared publications - Sung Wook Hwang
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
2 shared publications - Da-In Park
Research Institute of Nursing Innovation, College of Nursing, Kyungpook National University, Daegu, South Korea
1 shared publication - Dong-Hoon Yang
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
1 shared publication - Hee Seung Hong
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
1 shared publication
Latest Publications
- Open Access
- 30 May 2025
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25 (1) , 1-11
Effectiveness of an app-based walking program for obese patients with inflammatory bowel disease in Korea: a single-blind parallel-group randomized clinical trial
Obesity in patients with inflammatory bowel disease (IBD) not only exacerbates symptoms but also interferes with treatment and leads to additional complications. Therefore, managing weight loss and preventing obesity are crucial. This study was designed to develop and implement a 10-week walking exercise program, facilitated by a mobile application, to evaluate its effectiveness in managing weight in obese IBD patients. This study was designed as a single-blind parallel-group randomized clinical trial. We enrolled 54 participants, randomly allocating 27 to the intervention group and 27 to the control group. The intervention group received educational materials, such as videos, and participants were instructed to walk a minimum of 7,000 steps on at least five days each week for a duration of 10 weeks. Additionally, they were required to submit weekly updates on weight-related information to the researchers. The primary outcomes measured were body mass index (BMI), body fat percentage, and skeletal muscle mass. Secondary outcomes included perceived stress, fatigue, and quality of life. A total of 49 participants were included in the data collection (intervention group: n = 24, control group: n = 25). Post-intervention, the intervention group demonstrated significant reductions in BMI (t = 3.57, p =.001) and body fat percentage (Z = 3.11, p =.002) compared to the control group. Furthermore, perceived stress (t = 2.20, p =.038) and fatigue (t = 2.10, p =.047) significantly decreased in the intervention group, but no significant differences were observed when compared to the control group. The 10-week walking program utilizing a mobile app effectively reduced body fat among participants, indicating its potential to improve health management in clinical settings. Further research is necessary to explore changes in muscle mass and psychological variables. Korea Clinical Trials Registry number KCT0009461, 24/05/2024.
- 30 May 2025
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25 (1) , 1-11
Open AccessEffectiveness of an app-based walking program for obese patients with inflammatory bowel disease in Korea: a single-blind parallel-group randomized clinical trial
Obesity in patients with inflammatory bowel disease (IBD) not only exacerbates symptoms but also interferes with treatment and leads to additional complications. Therefore, managing weight loss and preventing obesity are crucial. This study was designed to develop and implement a 10-week walking exercise program, facilitated by a mobile application, to evaluate its effectiveness in managing weight in obese IBD patients. This study was designed as a single-blind parallel-group randomized clinical trial. We enrolled 54 participants, randomly allocating 27 to the intervention group and 27 to the control group. The intervention group received educational materials, such as videos, and participants were instructed to walk a minimum of 7,000 steps on at least five days each week for a duration of 10 weeks. Additionally, they were required to submit weekly updates on weight-related information to the researchers. The primary outcomes measured were body mass index (BMI), body fat percentage, and skeletal muscle mass. Secondary outcomes included perceived stress, fatigue, and quality of life. A total of 49 participants were included in the data collection (intervention group: n = 24, control group: n = 25). Post-intervention, the intervention group demonstrated significant reductions in BMI (t = 3.57, p =.001) and body fat percentage (Z = 3.11, p =.002) compared to the control group. Furthermore, perceived stress (t = 2.20, p =.038) and fatigue (t = 2.10, p =.047) significantly decreased in the intervention group, but no significant differences were observed when compared to the control group. The 10-week walking program utilizing a mobile app effectively reduced body fat among participants, indicating its potential to improve health management in clinical settings. Further research is necessary to explore changes in muscle mass and psychological variables. Korea Clinical Trials Registry number KCT0009461, 24/05/2024.
- Open Access
- 30 April 2022
- Published by The Ewha Medical Journal, Ewha Womans University College of Medicine in Ewha Medical Journal
- Vol. 45 (2) , 35-45
Medication Adherence in Korean Patients with Inflammatory Bowel Disease and Its Associated Factors
Inflammatory bowel disease (IBD) is a chronic inflammatory disease that occurs in the gastrointestinal tract that includes Crohn’s disease (CD) and ulcerative colitis (UC), and that may sometimes present with extraintestinal manifestations [1,2]. The prevalence of IBD is increasing in Asian countries including Korea [3-5]. Symptoms such as abdominal pain, diarrhea, weight loss, and a bloody stool are common to IBD. If the inflammation is not well controlled in affected patients, complications including intestinal stricture, fistula, perforation, and cancer can occur [6-8]. IBD is also a progressive disease, and it is important therefore to maintain appropriate medical interventions to prevent disease progression and reduce complications [9,10]. Adherence to medication regimens is thus vital and several studies have indicated in this regard that the prognosis is poorer in non-adherent IBD patients [11].
- 30 April 2022
- Published by The Ewha Medical Journal, Ewha Womans University College of Medicine in Ewha Medical Journal
- Vol. 45 (2) , 35-45
Open AccessMedication Adherence in Korean Patients with Inflammatory Bowel Disease and Its Associated Factors
Inflammatory bowel disease (IBD) is a chronic inflammatory disease that occurs in the gastrointestinal tract that includes Crohn’s disease (CD) and ulcerative colitis (UC), and that may sometimes present with extraintestinal manifestations [1,2]. The prevalence of IBD is increasing in Asian countries including Korea [3-5]. Symptoms such as abdominal pain, diarrhea, weight loss, and a bloody stool are common to IBD. If the inflammation is not well controlled in affected patients, complications including intestinal stricture, fistula, perforation, and cancer can occur [6-8]. IBD is also a progressive disease, and it is important therefore to maintain appropriate medical interventions to prevent disease progression and reduce complications [9,10]. Adherence to medication regimens is thus vital and several studies have indicated in this regard that the prognosis is poorer in non-adherent IBD patients [11].